Complejo Hospitalario de Toledo- H. Virgen de la Salud

Toledo 45004

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Lymphocytic Leukemia, Chronic

Studies at this site

• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
• Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia — Completed